Ergomed plc Director/PDMR Shareholding (5275B)
April 04 2017 - 4:50AM
UK Regulatory
TIDMERGO
RNS Number : 5275B
Ergomed plc
04 April 2017
Ergomed Plc
("Ergomed" or the "Company")
Director Dealing
Ergomed, a profitable UK-based group dedicated to the provision
of specialised services to the pharmaceutical industry and the
development of new drugs, announces that on 3 April 2017, Mr Peter
George, Chairman of the Company, bought 100,000 ordinary shares of
1p each in the Company ("Share(s)") at a price of 190p per Share.
Following this transaction, Mr Peter George holds 231,250 (0.6 per
cent. of the Company's issued share capital).
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial
responsibilities/person closely associated
---- -------------------------------------------------------------
a) Name Peter George
---- ------------------------- ----------------------------------
2 Reason for the notification
---- -------------------------------------------------------------
a) Position/status Chairman
---- ------------------------- ----------------------------------
b) Initial Initial Notification
notification
/Amendment
---- ------------------------- ----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- -------------------------------------------------------------
a) Name Ergomed Plc
---- ------------------------- ----------------------------------
b) Legal Entity 213800BVS8I9VMC1AP84
Identifier
---- ------------------------- ----------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- -------------------------------------------------------------
a) Description Ordinary shares of 1 pence each
of the
financial
instrument, GB00BN7ZCY67
type of
instrument
Identification
code
---- ------------------------- ----------------------------------
b) Nature Purchase of shares
of the
transaction
---- ------------------------- ----------------------------------
c) Currency GBP
---- ------------------------- ----------------------------------
d) Price(s) Price(s) Volume(s)
and volume(s)
---- ------------------------- ---------------- ----------------
190p 100,000
------------------------------ ---------------- ----------------
e) Aggregated
information
- Aggregated
volume
- Price 100,000
- Aggregated 190p
total
GBP190,000
------------------------------ ----------------------------------
f) Date of 03 April 2017
the transaction
---- ------------------------- ----------------------------------
g) Place of London Stock Exchange, AIM
the transaction
---- ------------------------- ----------------------------------
Enquiries:
Ergomed Plc Tel: +44 (0)
1483 503205
Miroslav Reljanovic (Chief Executive
Officer)
Stephen Stamp (Chief Financial
Officer)
Numis Securities (Nominated Advisor Tel: +44 (0)
and Broker) 20 7260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black (Joint Broker)
Stifel Nicolaus Europe Limited Tel: +44 (0)
20 7710 7600
Jonathan Senior (Joint Broker)
FTI Consulting (Financial PR) Tel: +44 (0)
20 3727 1000
Simon Conway / Mo Noonan / Natalie
Garland-Collins
MC-Services - for Continental Tel: +49 211
European enquiries 52925222
Anne Hennecke
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDMGGDLDLGNZG
(END) Dow Jones Newswires
April 04, 2017 05:50 ET (09:50 GMT)
Ergomed (LSE:ERGO)
Historical Stock Chart
From Apr 2024 to May 2024
Ergomed (LSE:ERGO)
Historical Stock Chart
From May 2023 to May 2024
